Results for tag: "Kisqali"

Kisqali (ribociclib) is a drug used to treat certain types of breast cancer. It is a type of targeted therapy, which works by blocking certain proteins that help cancer cells grow and divide. Kisqali is used in combination with other drugs to treat hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in postmenopausal women. It is also used to treat hormone receptor-positive, HER2-positive advanced or metastatic breast cancer in postmenopausal women. Kisqali is part of a growing market of breast cancer drugs, which includes other targeted therapies, hormone therapies, and chemotherapy. These drugs are used to treat different types of breast cancer, depending on the stage and type of cancer. They can be used alone or in combination with other treatments. The companies in the Kisqali market include Novartis, Pfizer, AstraZeneca, and Eli Lilly. Show Less Read more